粤公网安备 44011302004783号 美生物药Q3营收狂翻倍！跨境掘金秘籍！
2025-11-07 00:57:15AI工具
Ligand Pharmaceuticals (LGND) reported strong Q3 2025 financial results, exceeding market expectations in both revenue and EPS. This highlights the resilience of the biopharmaceutical sector and offers insights for Chinese跨境从业者 into global healthcare trends, innovation, and investment opportunities. The company's success reflects its strategic focus on R&D and effective market strategies.
发布于 2025-11-07
人民币汇率走势
CNY
关注我们
新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有，未经许可，禁止以任何形式转载。